उत्पाद विवरण
Alrubicin 50 mg Injection is a potent chemotherapy agent designed to combat a variety of cancers, including but not limited to breast, stomach, head and neck, liver, lung, and blood cancers, as well as malignant lymphomas and sarcomas. This injectable medication functions by inhibiting the growth and proliferation of cancer cells, effectively hindering their ability to spread throughout the body. While Alrubicin shows promise in the treatment of adult patients, it is important to note that its safety and efficacy in children have not been fully established, warranting caution in pediatric applications. Patients receiving Alrubicin should be monitored closely for potential side effects, as with any chemotherapy treatment. This medication plays a crucial role in personalized cancer therapy, contributing to improved outcomes for many individuals battling these aggressive diseases. As with any treatment plan, it's vital to discuss the benefits and risks of Alrubicin with a healthcare provider to ensure the best possible approach for managing cancer. With ongoing research, Alrubicin continues to be a significant option in the fight against various malignancies, reflecting the evolving landscape of oncology.Precision-Formulated for Oncology NeedsAlrubicin 50 mg Injection is manufactured to meet stringent quality standards, ensuring reliable potency for oncology treatment. With a focus on adult use, this preparation provides essential support for healthcare professionals managing antineoplastic therapies, with distribution originating from India.
Stable and Convenient PackagingPackaged in a single vial per box, Alrubicin maintains its integrity under proper storage conditions of 2-8C. Clear labeling and prescription-only dispensing offer both safety and convenience to medical facilities and pharmacy partners.
FAQ's of Alrubicin 50 mg Injection:
Q: How should Alrubicin 50 mg Injection be stored?
A: Alrubicin 50 mg Injection should be stored in a refrigerator at temperatures between 2-8C to maintain its effectiveness and prevent contamination. Do not freeze the vial and protect it from direct sunlight.
Q: What is the recommended route of administration for Alrubicin 50 mg Injection?
A: This medication is designated for intravenous use only and must be administered by a healthcare professional, typically in a hospital or clinical setting.
Q: When is Alrubicin 50 mg Injection typically used in treatment?
A: Alrubicin is commonly prescribed for adult oncology patients as part of cancer treatment regimens, under direct supervision and guidance of a doctor.
Q: Where is Alrubicin 50 mg Injection manufactured and available for distribution?
A: Alrubicin is produced in India and is available to distributors, exporters, suppliers, traders, and wholesalers both locally and for international markets.
Q: What is the process for obtaining Alrubicin 50 mg Injection?
A: This injection is available strictly by prescription. Authorized medical practitioners prescribe it, and it is dispensed by licensed pharmacies and medical suppliers.
Q: How does Alrubicin 50 mg Injection benefit patients?
A: Alrubicin contains doxorubicin hydrochloride, an antineoplastic agent that interferes with cancer cell growth and proliferation, providing therapeutic benefit in several adult-onset cancers when used according to clinical guidelines.
Send Email 
जांच भेजें
जांच भेजें
एसएमएस भेजें
मुझे निःशुल्क कॉल करें
English
Spanish
French
German
Italian
Chinese (Simplified)
Japanese
Korean
Arabic
Portuguese